Ram Sanyogita Sanya, Hussainy Safeera, Henning Marcus, Stewart Kay, Jensen Maree, Russell Bruce
a Pharmacy Law , University of Auckland , Auckland , New Zealand.
b Centre for Medicine Use and Safety , Monash University , Melbourne , Australia.
Subst Use Misuse. 2017 Sep 19;52(11):1387-1392. doi: 10.1080/10826084.2017.1281313. Epub 2017 Apr 21.
Cognitive enhancement is the use of prescription stimulant medicines by healthy individuals for nonmedical use in academic settings. Commonly used cognitive enhancers (CEs) include methylphenidate, amphetamines, and modafinil. To understand the motivation to use CEs, it is important to look beyond prevalence and explore the extent to which attitudes, beliefs, and intentions predict the decision to use CEs.
The study aimed to investigate what factors explain the decision to use CEs among tertiary students in New Zealand, using the Theory of Planned Behaviour (TPB).
Students from the Schools of Pharmacy, Nursing, Medicine, Law, and Accounting at a university in New Zealand were invited to complete a paper-based questionnaire. The questionnaire elicited students' attitudes, subjective norms, and perceived control toward illicit use of CEs using TPB. An exploratory factor analysis was conducted.
Response rate was 88.6% (442/499). Students who perceived CE use to be socially and ethically acceptable were more likely to use CEs (odds ratio, OR: 1.56, 95% confidence interval, 95% CI: 1.153-2.105, p = 0.004). Students who were concerned about the health impact of CE use were less likely to use CEs (OR: 0.54, 95% CI: 0.492-0.826, p = 0.001). Students who believed that CE use was approved were more likely to use them (OR: 1.648, CI: 1.193-2.278, p = 0.002).
This research supports the notion that the decision to use CEs is not just an autonomous choice that occurs in isolation. Attitudes on the ethical and social acceptability of CE use were more likely to drive the decision to use CEs. The study provides the impetus for an integrative discussion by health care professionals and academics on the impact of attitudes, social norms, and advocates on the decision to use CEs.
认知增强是指健康个体在学术环境中出于非医疗目的使用处方兴奋剂药物。常用的认知增强剂(CEs)包括哌甲酯、苯丙胺和莫达非尼。为了理解使用认知增强剂的动机,重要的是超越流行率,探索态度、信念和意图在多大程度上预测使用认知增强剂的决定。
本研究旨在运用计划行为理论(TPB)调查新西兰大学生中使用认知增强剂的决定受哪些因素影响。
邀请新西兰一所大学的药学院、护理学院、医学院、法学院和会计学院的学生完成纸质问卷。该问卷运用计划行为理论引出学生对非法使用认知增强剂的态度、主观规范和感知控制。进行了探索性因素分析。
回复率为88.6%(442/499)。认为使用认知增强剂在社会和伦理上可接受的学生更有可能使用认知增强剂(优势比,OR:1.56,95%置信区间,95%CI:1.153 - 2.105,p = 0.004)。担心使用认知增强剂对健康有影响的学生使用认知增强剂的可能性较小(OR:0.54,95%CI:0.492 - 0.826,p = 0.001)。认为使用认知增强剂得到认可的学生更有可能使用它们(OR:1.648,CI:1.193 - 2.278,p = 0.002)。
本研究支持这样一种观点,即使用认知增强剂的决定并非孤立发生的自主选择。对使用认知增强剂在伦理和社会可接受性方面的态度更有可能推动使用认知增强剂的决定。该研究为医疗保健专业人员和学者就态度、社会规范及倡导者对使用认知增强剂决定的影响展开综合讨论提供了动力。